A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes (Q42742172)
Jump to navigation
Jump to search
scientific article published on November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes |
scientific article published on November 2010 |
Statements
1 reference
A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes (English)
1 reference
Jayaram S
1 reference
Hariharan RS
1 reference
Madhavan R
1 reference
Periyandavar I
1 reference
Samra SS
1 reference
1 November 2010
1 reference
1 reference